NicholasFidelmanMD
Radiology • San Francisco, CAInterventional Neuroradiology, Vascular & Interventional Radiology
Assistant Professor, Radiology, UCSF School of Medicine
Dr. Fidelman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
505 Parnassus Avenue, Box 0628
Ucsf Department Of Radiology
San Francisco, CA 94143Phone+1 415-353-1000Fax+1 415-476-0616
Education & Training
University of California (San Francisco)Residency, Radiology-Diagnostic, 2003 - 2007
St Mary's Hospital and Medical CenterInternship, Internal Medicine, 2002 - 2003- University of California San Francisco School of MedicineClass of 2002
Certifications & Licensure
CA State Medical License 2003 - 2025- American Board of Radiology Interventional Radiology and Diagnostic Radiology
Clinical Trials
- Yttrium-90 Radioembolization With Glass Microspheres (TheraSphere) for Patients With Hepatocellular Carcinoma Start of enrollment: 2010 May 01
- Yttrium-90 Radioembolization Using Glass Microspheres (TheraSphere) for Patients With Liver Metastases Start of enrollment: 2010 May 01
- Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer Start of enrollment: 2012 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 297 citationsDownstaging of hepatocellular cancer before liver transplant: Long-term outcome compared to tumors within Milan criteriaFrancis Y. Yao, Neil Mehta, Jennifer A. Flemming, Jennifer L. Dodge, Bilal Hameed
Hepatology. 2015-06-01 - 13 citationsFrontiers of therapy for hepatocellular carcinoma.Michael Heller, Neehar D. Parikh, Nicholas Fidelman, Dawn Owen
Abdominal Radiology. 2021-04-10 - 47 citationsIntention to treat outcome of T1 hepatocellular carcinoma with the “wait and not ablate” approach until meeting T2 criteria for liver transplant listingNeil Mehta, Monika Sarkar, Jennifer L. Dodge, Nicholas Fidelman, John P. Roberts
Liver Transplantation. 2016-02-01
Lectures
- Phase I prospective trial of TAS-102 (trifluride and tipiracil) and radioembolization with 90Y resin microspheres for chemo-refractory colorectal liver metastases.ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/25/2020
- WOMEN’S IMAGING IN WINE COUNTRY NAPA, CALIFORNIAUCSF - Helen Diller Family Comprehensive Cancer Center, Napa, California - 9/29/2013
- WOMEN’S IMAGING IN WINE COUNTRY NAPA, CALIFORNIAUCSF - Helen Diller Family Comprehensive Cancer Center, Napa, California - 9/29/2013
Press Mentions
Breaking the Boundaries Between Radiology and Oncology: GU Oncology Profiles Thomas a. Hope, MDApril 28th, 2022- K. Pallav Kolli, MD, Appointed Chief of Interventional RadiologyOctober 18th, 2021
- Recognizing the Role of Nurses in the Growth of Radiology Services at UCSFMay 7th, 2021
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
